zirconium has been researched along with Neoplasms in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (13.64) | 18.7374 |
1990's | 2 (2.27) | 18.2507 |
2000's | 4 (4.55) | 29.6817 |
2010's | 48 (54.55) | 24.3611 |
2020's | 22 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kim, BC; Kim, M; Lee, CY; Shim, MS; Truong Hoang, Q | 1 |
Adumeau, P; Bernhard, C; Boswinkel, M; Da Costa, L; Denat, F; Goncalves, V; Heskamp, S; Moreau, M; Raavé, R; van Gool, AJ; Wessels, HJCT | 1 |
Chu, Y; Li, Y; Ma, X; Pan, W; Pang, S; Shan, J; Wang, X; Wu, H; Wu, Y; Zhou, G; Zou, B | 1 |
Arnold, TC; Barry, T; Bhatt, NB; Bruestle, K; Danton, M; Doubrovin, M; Dudgeon, D; Edelmann, KH; Fredriksson, F; Gartner, H; Giurleo, JT; Griesemer, A; Gurer, C; Hermann, A; Hickey, C; Kelly, MP; Kirshner, JR; Kyratsous, CA; Ma, D; Macdonald, LE; Makonnen, S; Mintz, A; Murphy, A; Olson, WC; Popke, J; Potocky, T; Tavaré, R; Thurston, G; Tu, N; Ullman, E | 1 |
Du, B; Du, X; Guo, J; Huang, J; Li, Y; Liu, C; Zhou, Y | 1 |
Chae, JH; Cheng, Z; Choi, PS; Hur, MG; Lee, JY; Park, JH; Wadas, T | 1 |
Boswinkel, M; de Roode, KE; Hoeben, FJM; Kleijn, LHJ; Nagarajah, J; Rijpkema, M; Robillard, MS; Rossin, R; Vlastara, M | 1 |
Aprile, FA; Ge, Y; Long, NJ; Ma, MT; Pham, TT; Yue, TTC | 1 |
Arroyo, A; Lewis, JS; Lyashchenko, SK | 1 |
Akehi, M; Kishi, Y; Kobayashi, K; Matsuura, E; Ohno, E; Sasaki, T; Shinohara, M; Takenaka, F; Yakushiji, H | 1 |
Ali, R; Alkahtani, SA; El-Wekil, MM; Mahmoud, AM; Mahnashi, MH | 1 |
Cai, Z; Chen, G; Du, X; Lin, X; Liu, X; Wei, Z; Wu, M; Xin, F; Yao, C; Zhang, D; Zhang, Z | 1 |
Häfner, SJ | 1 |
Alauddin, MM; Khawli, LA | 1 |
An, N; Gao, Y; Guo, C; Liu, Z; Meng, H; Qu, G; Wang, S; Yan, M; Yang, C | 1 |
Wenger, OS | 1 |
Gao, F; Guo, DK; Li, CX; Liu, MD; Wang, SB; Xie, BR; Yu, Y; Zhang, C; Zhang, XZ; Zhong, Z | 1 |
Deng, Z; Fang, C; Li, X; Ma, X; Peng, X; Zeng, YJ | 1 |
An, YS; Lee, SJ; Park, BN; Ryu, EK; Yoon, JK | 1 |
Craik, CS; Evans, MJ; Flavell, RR; Fong, L; Lee, CY; Oh, DY; Ruggero, D; Seo, Y; Truillet, C; VanBrocklin, HF; Wang, CI; Wang, YH; Wei, J; Xu, Y | 1 |
Chen, H; Dai, W; Ding, Q; Li, B; Liu, D; Liu, J; Liu, Y; Shi, C; Xiao, J | 1 |
Bellotti, D; Remelli, M | 1 |
Brouwers, AH; de Groot, DJA; de Vries, EGE; Elias, SG; Giesen, D; Gietema, JA; Hooiveld-Noeken, JS; Jalving, M; Kist de Ruijter, L; Kok, IC; Lu, H; Lub-de Hooge, MN; Nguyen, MTL; Vasiljeva, O | 1 |
Fang, W; Guo, C; Jin, Y; Ma, W; Wang, X; Wang, Z; Wu, X | 1 |
Alsaid, H; Clarke, N; Cleveland, M; Fieles, W; Hoang, B; Hunsinger, K; Jucker, BM; Long, ER; Matheny, C; Rambo, MV; Skedzielewski, T; Tunstead, J; Vugts, DJ | 1 |
Abiraj, K; Adessi, C; Bensch, F; Brouwers, AH; de Jong, JR; de Vries, EGE; Gietema, JA; Jacob, W; James, I; Jorritsma-Smit, A; Lamberts, LE; Lub-de Hooge, MN; Meneses-Lorente, G; Schröder, CP; Smeenk, MM; Terwisscha van Scheltinga, AGT; Thomas, M; Weisser, M | 1 |
Boerman, O; Denat, F; Goncalves, V; Heskamp, S; Raavé, R; Rijpkema, M | 1 |
Fu, C; Huang, Z; Meng, X; Ren, J; Ren, X; Tan, L; Wu, Q; Zhou, H | 1 |
Barnhart, TE; Cai, W; Cheng, L; Ellison, PA; Goel, S; He, Q; Jiang, D; Kang, L; Liu, Z; Ni, D; Siamof, CM; Yu, B; Yu, F; Zhang, H | 1 |
Cai, W; Ehlerding, EB; Huang, P; Jiang, D; Ni, D | 1 |
Adumeau, P; Davydova, M; Zeglis, BM | 1 |
Dilworth, JR; Pascu, SI | 1 |
Cao, F; Chen, X; Fu, C; Huang, Z; Liang, P; Meng, X; Ren, J; Ren, X; Su, L; Tan, L; Wu, Q; Yu, J; Zhou, H | 1 |
Boellaard, R; de Vet, HCW; der Houven van Oordt, CWM; Heijtel, DF; Hoekstra, OS; Huisman, MC; Jauw, YWS; Lammertsma, AA; van Dongen, GAMS; Verheul, HM; Vugts, DJ; Zijlstra, JM; Zweegman, S | 1 |
Cheung, HK; de Vries, EGE; Friedrich, M; Lub-de Hooge, MN; Schröder, CP; Sternjak, A; Stienen, S; van Scheltinga, AGTT; Waaijer, SJH; Warnders, FJ | 1 |
Guo, C; He, L; Jia, Q; Jia, Z; Lu, S; Su, F; Wang, M; Zhang, Z; Zhou, N | 1 |
Al-Dulaymi, M; Badea, I; Fonge, H; Hajdu, I; Makhlouf, A; Michel, D; Solomon, VR; Wasan, KM | 1 |
Feng, J; Li, CX; Li, X; Liu, T; Liu, WL; Song, W; Ye, JJ; Yu, WY; Zeng, JY; Zhang, XZ; Zou, MZ | 1 |
Chen, X; Cui, Y; Liu, Y; Luo, L; Ma, T; Meng, X; Tan, L; Wang, X; Wu, Q | 1 |
Fu, C; Gou, L; Li, H; Li, L; Liang, P; Long, D; Meng, X; Rao, W; Ren, J; Ren, X; Tan, L; Wu, Q; Xia, N; Yu, J | 1 |
Chang, W; Huang, H; Jia, Q; Qiao, C; Wang, H; Wang, Y; Wang, Z; Zhang, H; Zhang, R | 1 |
van Dongen, GA; Visser, GW; Vugts, DJ | 1 |
Carlin, S; Drobjnak, M; Evans, MJ; Lewis, JS; Livingston, PO; Ragupathi, G; Rice, SL; Sawada, R; Scholz, WW; Sevak, KK; Viola-Villegas, NT; Wu, X | 1 |
Bol, A; Bonifazi, D; Bouchat, V; Bouzin, C; Deumer, G; Feron, O; Gallez, B; Grégoire, V; Haufroid, V; Karmani, L; Labar, D; Levêque, P; Lucas, S; Marega, R; Michiels, C; Vander Borght, T | 1 |
Adam, J; Kadeřávek, J; Kužel, F; Rehák, Z; Vašina, J | 1 |
Bhadrasetty, V; Chaudhary, A; Choyke, P; Coble, V; Elbuluk, O; Griffiths, GL; Histed, S; Jagoda, EM; Kuo, F; Lane, K; Paik, CH; St Croix, B; Szajek, LP; Szot, C; Vasalatiy, O; Williams, MR; Wong, K; Wu, H; Xu, B | 1 |
Boerman, OC; Brinkmann, U; Oyen, WJ; Perk, L; Rijpkema, M; van de Watering, FC | 1 |
Abdel-Atti, D; Binderup, T; Fayad, ZA; Irwin, CP; Lewis, JS; Longo, VA; Mulder, WJ; Pérez-Medina, C; Reiner, T; Ruiz-Cabello, J; Zhang, Y | 1 |
Boellaard, R; Harry Hendrikse, N; Huisman, MC; Molthoff, CF; Van Dongen, GA; Visser, GW; Vugts, DJ; Windhorst, AD | 1 |
Környei, J; Mikecz, P; Tóth, G | 1 |
Gehring, T; Mendler, CT; Schwaiger, M; Skerra, A; Wester, HJ | 1 |
Chaal, J; Conti, M; Soderlund, AT; Tjio, G; Totman, JJ; Townsend, DW | 1 |
Al-Fahdawi, MQ; Al-Qubaisi, MS; Alhassan, FH; El Zowalaty, ME; Naadja, SE; Rasedee, A; Rosli, R; Taufiq-Yap, YH; Webster, TJ | 1 |
Xianwei, M | 1 |
Báez, A; Cabán, J; Colón, JL; González, ML; Hernández, C; Ortiz, M; Rodríguez, A | 1 |
Chu, JM; Feng, YQ; Jiang, HP; Lan, MD; Liu, P; Yang, N; Yuan, BF; Zheng, F | 1 |
Brewster, M; Cannarile, MA; Christen, R; Coveler, AL; Gomez-Roca, C; Guarin, E; Heil, F; Le Tourneau, C; Mahalingam, D; Menke-van der Houven van Oordt, CW; Meresse, V; Nayak, TK; Rüttinger, D; van der Graaf, WT; van Herpen, C; Verheul, HM; Walz, AC; Weigand, S | 1 |
Firestein, R; Gupta, N; Li, D; Marik, J; Ogasawara, A; Pacheco, G; Scales, SJ; Terwisscha van Scheltinga, AG; Tinianow, JN; Vanderbilt, AN; Williams, SP | 1 |
Das, S; Grimm, J; Mulder, WJ; Pérez-Medina, C; Shaffer, TM; Zhao, Y | 1 |
Codd, R; Katsifis, A; Lifa, T; Tieu, W | 1 |
Aerts, HJ; Dubois, L; Lambin, P; Perk, L; van Dongen, GA; Vermaelen, P; Wouters, BG | 1 |
Ashman, K; Villar, EL | 1 |
de Jong, JR; de Korte, MA; de Vries, EG; den Dunnen, WF; Garcia-Echeverria, C; Hollema, H; Jensen, MR; Lub-de Hooge, MN; Nagengast, WB; Oude Munnink, TH; Quadt, C; Schröder, CP; Timmer-Bosscha, H; van Dongen, GA | 1 |
Grimm, J; Holland, JP; Lewis, JS; Ruggiero, A | 1 |
McCabe, KE; Wu, AM | 1 |
Gwirc, SN; Marino, NR; Negreira, CA | 1 |
Kamal, A; Kumar, BA; Kumar, MS; Shankaraiah, N; Suresh, P | 1 |
Chen, X; Jacobson, O; Kiesewetter, DO; Liu, S; Ma, Y; Niu, G; Sun, X; Szajek, LP; Weiss, ID; Yan, Y; Zhu, L | 1 |
Carlin, S; Divilov, V; Heneweer, C; Holland, JP; Lewis, JS | 1 |
Keliher, EJ; Lewis, JS; Marinelli, B; Nahrendorf, M; Newton, A; Pittet, MJ; Weissleder, R; Yoo, J | 1 |
Alberini, JL; Bellet, D; Pecking, AP | 1 |
Batteas, JD; Clearfield, A; Diaz, A; Hussain, MD; Saxena, V | 1 |
Lee, FT; Scott, AM | 1 |
MEALEY, J | 1 |
KUZMA, JF; ZANDER-PRINCIPATI, GE | 3 |
BENSTED, JP; CROOKALL, JO | 1 |
HILL, JM; LOEB, E; SPEER, RJ | 1 |
Albano, R; Comoglio, PM; Giaccone, G; Kloet, RW; Leemans, CR; Perk, LR; Stigter-van Walsum, M; van Dongen, GA; Visser, GW; Vosjan, MJ | 1 |
Koch, M; McPherson, TA | 1 |
Haisma, HJ; Herscheid, JD; Kievit, E; Klok, RP; Meijs, WE; Pinedo, HM; van Gog, FB | 1 |
Ghosh, S; Sharma, A; Talukder, G | 1 |
Pylev, LN | 1 |
Bray, PF; Madsen, A; Wu, JT | 1 |
Chu, TM; Reynoso, G | 1 |
Black, PH; Collins, JJ | 1 |
Hansen, HJ; Krupey, J; Lo Gerfo, P | 1 |
15 review(s) available for zirconium and Neoplasms
Article | Year |
---|---|
Methods for the Production of Radiolabeled Bioagents for ImmunoPET.
Topics: Animals; Antibodies; Chelating Agents; Humans; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Zirconium | 2024 |
Advances in Immuno-PET for the Detection of Cancer and Assessment of Response to Therapy.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Radioisotopes; Zirconium | 2021 |
Current Perspectives on
Topics: Animals; Antigens, CD20; Biomarkers; Biomarkers, Tumor; Disease Management; Humans; Immune Checkpoint Inhibitors; Immunoconjugates; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Zirconium | 2020 |
Applications of ROS-InducedZr-MOFs Platform in Multimodal Synergistic Therapy.
Topics: Antineoplastic Agents; Cell Survival; Combined Modality Therapy; Drug Carriers; Humans; Metal-Organic Frameworks; Neoplasms; Photochemotherapy; Reactive Oxygen Species; Zirconium | 2021 |
Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator.
Topics: Animals; Antineoplastic Agents; Chelating Agents; Chemistry, Pharmaceutical; COVID-19 Drug Treatment; Deferoxamine; Electrochemistry; Electrolytes; Humans; Hydrogen-Ion Concentration; Ions; Iron; Iron Chelating Agents; Iron Overload; Kinetics; Ligands; Metals; Neoplasms; Potentiometry; SARS-CoV-2; Temperature; Zirconium | 2021 |
Topics: Animals; Chelating Agents; Deferoxamine; Drug Delivery Systems; Drug Discovery; Humans; Immunoconjugates; Neoplasms; Positron-Emission Tomography; Radiochemistry; Radioisotopes; Zirconium | 2017 |
Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Topics: Animals; Copper Radioisotopes; Fluorine Radioisotopes; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Molecular Imaging; Nanoparticles; Neoplasms; Positron-Emission Tomography; Radioisotopes; Silicon Dioxide; Zirconium | 2018 |
The chemistry of PET imaging with zirconium-89.
Topics: Animals; Antibodies, Monoclonal; Coordination Complexes; Humans; Hydroxamic Acids; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Siderophores; Zirconium | 2018 |
89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals.
Topics: Animals; Antibodies, Monoclonal; Humans; Neoplasms; Positron-Emission Tomography; Zirconium | 2013 |
[Current trends in using PET radiopharmaceuticals for diagnostics in oncology].
Topics: Carbon Radioisotopes; Fluorine Radioisotopes; Gallium Radioisotopes; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Zirconium | 2014 |
Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.
Topics: Antibodies; Humans; Molecular Imaging; Neoplasms; Positron-Emission Tomography; Radiography; Radioisotopes; Zirconium | 2014 |
89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?
Topics: Antibodies, Monoclonal; Drug Delivery Systems; Humans; Isotope Labeling; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Zirconium | 2015 |
Phosphoproteomics and cancer research.
Topics: Animals; Antineoplastic Agents; Chromatography, Affinity; Chromatography, Ion Exchange; Computational Biology; Drug Delivery Systems; Electrophoresis, Gel, Two-Dimensional; Humans; Immunoprecipitation; Mass Spectrometry; Mice; Neoplasm Proteins; Neoplasms; Peptide Mapping; Phosphoproteins; Phosphorylation; Protein Array Analysis; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proteomics; Signal Transduction; Titanium; Zirconium | 2009 |
Zirconium. An abnormal trace element in biology.
Topics: Animals; Environmental Exposure; Female; Humans; Male; Mutagens; Neoplasms; Plants; Soil; Zirconium | 1992 |
[The role of modifying factors in the carcinogenic effect of asbestos and asbestos-containing dusts].
Topics: Animals; Asbestos; Citrates; Citric Acid; Dust; Humans; Neoplasms; Zirconium | 1987 |
2 trial(s) available for zirconium and Neoplasms
Article | Year |
---|---|
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Drug Monitoring; Female; Gene Expression; Humans; Male; Middle Aged; Molecular Targeted Therapy; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-3; Treatment Outcome; Zirconium | 2017 |
First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Disease Progression; Female; Humans; Hyaluronan Receptors; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Zirconium | 2016 |
71 other study(ies) available for zirconium and Neoplasms
Article | Year |
---|---|
Pro-oxidant drug-loaded porphyrinic zirconium metal-organic-frameworks for cancer-specific sonodynamic therapy.
Topics: Metal-Organic Frameworks; Neoplasms; Oxidants; Prodrugs; Reactive Oxygen Species; Zirconium | 2022 |
Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors.
Topics: Cell Line, Tumor; Fluorescent Dyes; Humans; Immunoconjugates; Neoplasms; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium | 2022 |
Lipid membrane anchoring and highly specific fluorescence detection of cancer-derived exosomes based on postfunctionalized zirconium-metal-organic frameworks.
Topics: Exosomes; Fluorescence; Humans; Lipids; Metal-Organic Frameworks; Neoplasms; Phthalic Acids; Zirconium | 2022 |
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054.
Topics: Animals; Antibodies, Bispecific; CD8-Positive T-Lymphocytes; Cytokines; Humans; Lymphocytes, Tumor-Infiltrating; Macaca fascicularis; Mice; Neoplasms; Positron-Emission Tomography; Radioisotopes; Tumor Microenvironment; Zirconium | 2022 |
Robust Dual Enzyme Cascade-Catalytic Cholesterol Depletion for Reverse Tumor Multidrug Resistance.
Topics: ATP Binding Cassette Transporter, Subfamily B; Catalysis; Cell Line, Tumor; Cholesterol; Cholesterol Oxidase; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Metal-Organic Frameworks; Nanoparticles; Neoplasms; Zirconium | 2022 |
Theranostics through Utilizing Cherenkov Radiation of Radioisotope Zr-89 with a Nanocomposite Combination of TiO
Topics: Animals; Manganese Compounds; Mice; Neoplasms; Oxides; Positron-Emission Tomography; Precision Medicine; Radioisotopes; Zirconium | 2023 |
Click-to-Release: Cleavable Radioimmunoimaging with [
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cyclooctanes; Mice; Neoplasms; Positron-Emission Tomography; Radioimmunodetection; Trastuzumab; Zirconium | 2023 |
Site-Specific
Topics: Animals; Cell Line, Tumor; Chelating Agents; Deferoxamine; Gallium Radioisotopes; Immunoconjugates; Methionine; Mice; Neoplasms; Positron-Emission Tomography; Racemethionine; Tissue Distribution; Trastuzumab; Zirconium | 2023 |
Novel single-chain variant of antibody against mesothelin established by phage library.
Topics: Animals; Cell Line, Tumor; CHO Cells; Cloning, Molecular; Cricetulus; GPI-Linked Proteins; Humans; Male; Mesothelin; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Neoplasms; Peptide Library; Positron Emission Tomography Computed Tomography; Radioisotopes; Radiopharmaceuticals; Recombinant Proteins; Single-Chain Antibodies; Xenograft Model Antitumor Assays; Zirconium | 2019 |
Facile fabrication of a novel 3D rose like lanthanum doped zirconia decorated reduced graphene oxide nanosheets: An efficient electro-catalyst for electrochemical reduction of futuristic anti-cancer drug salinomycin during pharmacokinetic study.
Topics: Biosensing Techniques; Catalysis; Electrochemical Techniques; Electrodes; Graphite; Humans; Lanthanum; Neoplasms; Pyrans; Zirconium | 2020 |
Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; Cell Line, Tumor; Cell Survival; CpG Islands; Humans; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha Subunit; Immunotherapy; Male; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Zirconium | 2020 |
High hopes and high honours for cancer immunotherapy.
Topics: Humans; Immunotherapy; Medicine; Neoplasms; Zirconium | 2019 |
Cell-cargo mediated ZrN nanoparticle for the synergetic phototherapy on both of mice and rabbits.
Topics: Animals; Cell Line, Tumor; Female; Humans; Macrophages; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Photochemotherapy; Phototherapy; Rabbits; Reactive Oxygen Species; Ultrasonography; Zirconium | 2020 |
A bright future for photosensitizers.
Topics: Fluorescence; Humans; Ligands; Neoplasms; Photosensitizing Agents; Zirconium | 2020 |
Integration of a porous coordination network and black phosphorus nanosheets for improved photodynamic therapy of tumor.
Topics: Animals; Benzoquinones; Cell Line, Tumor; Drug Delivery Systems; Folic Acid; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Metal-Organic Frameworks; Mice; Nanostructures; Neoplasms; Phosphorus; Photochemotherapy; Porosity; Porphyrins; Reactive Oxygen Species; Xenograft Model Antitumor Assays; Zirconium | 2020 |
One Stone Two Birds: Zr-Fc Metal-Organic Framework Nanosheet for Synergistic Photothermal and Chemodynamic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Catalysis; Cell Line, Tumor; Combined Modality Therapy; Ferrous Compounds; Hydroxyl Radical; Hyperthermia, Induced; Infrared Rays; Metal-Organic Frameworks; Metallocenes; Mice; Nanostructures; Neoplasms; Photochemotherapy; Zirconium | 2020 |
An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET Radiotracers.
Topics: Animals; Antibodies; B7-H1 Antigen; Cell Line, Tumor; Disease Models, Animal; Humans; Kinetics; Mice; Molecular Weight; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Single-Chain Antibodies; Tissue Distribution; Zirconium | 2020 |
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 Probody.
Topics: B7-H1 Antigen; Humans; Neoplasms; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium | 2021 |
Construction of a nanotheranostic system Zr-MOF@PPa/AF@PEG for improved photodynamic therapy effects based on the PDT‑oxygen consumption and hypoxia sensitive chemotherapeutic drug.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chlorophyll; Drug Liberation; Female; Flavonoids; Humans; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Photochemotherapy; Polyethylene Glycols; Singlet Oxygen; Theranostic Nanomedicine; Tumor Microenvironment; Zirconium | 2021 |
Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Female; Ferrosoferric Oxide; Humans; Immunohistochemistry; Isotope Labeling; Macrophages; Mice; Mice, Nude; Neoplasms; Radioisotopes; Radiopharmaceuticals; Receptor, ErbB-3; Tissue Distribution; Transplantation, Heterologous; Zirconium | 2017 |
Microwave-Activated Mn-Doped Zirconium Metal-Organic Framework Nanocubes for Highly Effective Combination of Microwave Dynamic and Thermal Therapies Against Cancer.
Topics: Animals; Female; Hep G2 Cells; Humans; Hyperthermia, Induced; Manganese; Metal-Organic Frameworks; Mice, Inbred ICR; Microwaves; Models, Molecular; Nanoparticles; Neoplasms; Reactive Oxygen Species; Zirconium | 2018 |
Reassembly of
Topics: Animals; Cell Line, Tumor; Cell Membrane; Liposomes; Mice; Neoplasms; Positron-Emission Tomography; Theranostic Nanomedicine; Tissue Distribution; Zirconium | 2018 |
Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability.
Topics: Animals; Chelating Agents; Humans; Immunoconjugates; Lutetium; Mesylates; Mice; Mice, Nude; Neoplasms; Positron-Emission Tomography; Radioisotopes; Sulfhydryl Compounds; Zirconium | 2018 |
Mitochondria-targeted zirconium metal-organic frameworks for enhancing the efficacy of microwave thermal therapy against tumors.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Hyperthermia, Induced; Metal-Organic Frameworks; Mice; Microwaves; Mitochondria; Nanoparticles; Neoplasms; Organophosphates; Polyethylene Glycols; Zirconium | 2018 |
Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
Topics: Antibodies, Monoclonal; Humans; Neoplasms; Positron-Emission Tomography; Radioisotopes; Reproducibility of Results; Zirconium | 2018 |
Molecular Imaging of Radiolabeled Bispecific T-Cell Engager
Topics: Animals; Antibodies, Bispecific; Biomarkers; Carcinoembryonic Antigen; Cell Line, Tumor; Disease Models, Animal; Flow Cytometry; Heterografts; Humans; Mice; Molecular Imaging; Neoplasms; Positron-Emission Tomography; Radioisotopes; T-Lymphocytes; Zirconium | 2018 |
Two-dimensional oriented growth of Zn-MOF-on-Zr-MOF architecture: A highly sensitive and selective platform for detecting cancer markers.
Topics: Biomarkers, Tumor; Biosensing Techniques; Cell Adhesion Molecules; Humans; Limit of Detection; Metal-Organic Frameworks; Neoplasms; Receptor Protein-Tyrosine Kinases; Zinc; Zirconium | 2019 |
A
Topics: Animals; Cell Survival; Deferoxamine; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; Imaging, Three-Dimensional; Lipids; Mice, Nude; Nanoparticles; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Surface-Active Agents; Tissue Distribution; Zirconium | 2018 |
Expandable Immunotherapeutic Nanoplatforms Engineered from Cytomembranes of Hybrid Cells Derived from Cancer and Dendritic Cells.
Topics: Animals; Antibodies; Cell Line, Tumor; Cell Membrane; Dendritic Cells; Histocompatibility Antigens Class II; Hyaluronan Receptors; Immunotherapy; Metal-Organic Frameworks; Mice; Mice, Nude; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Transplantation, Heterologous; Zirconium | 2019 |
Quercetin-Modified Metal-Organic Frameworks for Dual Sensitization of Radiotherapy in Tumor Tissues by Inhibiting the Carbonic Anhydrase IX.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Hypoxia; Cell Line, Tumor; Female; Humans; Metal-Organic Frameworks; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Quercetin; Radiation-Sensitizing Agents; Zirconium | 2019 |
Dual-Functional Supernanoparticles with Microwave Dynamic Therapy and Microwave Thermal Therapy.
Topics: Animals; Hep G2 Cells; Humans; Hyperthermia, Induced; Ionic Liquids; Mice; Microwaves; Nanoparticles; Neoplasms; Reactive Oxygen Species; Zirconium | 2019 |
Highly Stable and Long-Circulating Metal-Organic Frameworks Nanoprobes for Sensitive Tumor Detection In Vivo.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Lipid Bilayers; Materials Testing; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nanostructures; Neoplasm Transplantation; Neoplasms; Phosphatidic Acids; Polyethylene Glycols; Surface Properties; Zirconium | 2019 |
Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.
Topics: Animals; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Humans; Mice; Neoplasms; Positron-Emission Tomography; Radioisotopes; Zirconium | 2013 |
(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.
Topics: Animals; Antibodies, Anti-Idiotypic; Antigens, CD; Cell Line, Tumor; Diagnostic Imaging; Endoglin; Gold; Humans; Metal Nanoparticles; Mice; Neoplasms; Positron-Emission Tomography; Radiography; Receptors, Cell Surface; Tissue Distribution; Zirconium | 2014 |
Immuno-PET imaging of tumor endothelial marker 8 (TEM8).
Topics: Animals; Antibodies, Monoclonal, Humanized; Blotting, Western; Deferoxamine; Female; Humans; Immunoprecipitation; Mice; Mice, Nude; Microfilament Proteins; Molecular Imaging; Neoplasm Proteins; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Cell Surface; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zirconium | 2014 |
A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.
Topics: Animals; Chelating Agents; Disease Models, Animal; Fluorescent Dyes; Lipid Bilayers; Liposomes; Mice; Nanoparticles; Nanotechnology; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Zirconium | 2014 |
[PET radiopharmaceuticals: novelties and new possibilities].
Topics: Carbon Radioisotopes; Copper Radioisotopes; Electrons; Fluorine Radioisotopes; Gallium Radioisotopes; Half-Life; Humans; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Scandium; Yttrium Radioisotopes; Zirconium | 2014 |
⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
Topics: Amino Acids; Animals; Antibodies, Monoclonal; Breast Neoplasms; Contrast Media; Female; Half-Life; Humans; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Isotope Labeling; Mice; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Prognosis; Radioisotopes; Radiopharmaceuticals; Recombinant Proteins; Tissue Distribution; Zirconium | 2015 |
Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Topics: Carbon Radioisotopes; Contrast Media; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes; Zirconium | 2015 |
Cytotoxicity and physicochemical characterization of iron-manganese-doped sulfated zirconia nanoparticles.
Topics: Cell Proliferation; Humans; Iron; Manganese; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Photoelectron Spectroscopy; Sulfates; Tumor Cells, Cultured; X-Ray Diffraction; Zirconium | 2015 |
What potential is there for the use of ZrO2 nanostructures for image-guided thermotherapy?
Topics: Docetaxel; Humans; Hyperthermia, Induced; Nanoparticles; Neoplasms; Taxoids; Tomography, X-Ray Computed; Zirconium | 2015 |
Zirconium Phosphate Nanoplatelet Potential for Anticancer Drug Delivery Applications.
Topics: Apoptosis; Doxorubicin; Drug Carriers; Female; Humans; MCF-7 Cells; Nanoparticles; Neoplasms; Zirconium | 2016 |
Comprehensive profiling of ribonucleosides modification by affinity zirconium oxide-silica composite monolithic column online solid-phase microextraction - Mass spectrometry analysis.
Topics: Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Neoplasms; Ribonucleosides; Ribose; Silicon Dioxide; Solid Phase Microextraction; Tandem Mass Spectrometry; Zirconium | 2016 |
Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Flow Cytometry; Gene Expression; GPI-Linked Proteins; Humans; Immunoconjugates; Mesothelin; Mice; Molecular Targeted Therapy; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays; Zirconium | 2017 |
Near-Infrared Quantum Dot and
Topics: Animals; Infrared Rays; Isotopes; Luminescence; Luminescent Measurements; Male; Mice; Mice, Nude; Nanoparticles; Neoplasms; Optical Imaging; Quantum Dots; Sentinel Lymph Node; Zirconium | 2017 |
Octadentate Zirconium(IV)-Loaded Macrocycles with Varied Stoichiometry Assembled From Hydroxamic Acid Monomers using Metal-Templated Synthesis.
Topics: Chelating Agents; Coordination Complexes; Crystallography, X-Ray; Hydroxamic Acids; Ligands; Macrocyclic Compounds; Models, Molecular; Molecular Structure; Neoplasms; Positron-Emission Tomography; Zirconium | 2017 |
Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cetuximab; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasms; Positron-Emission Tomography; Radioisotopes; Reproducibility of Results; Staining and Labeling; Tissue Distribution; Zirconium | 2009 |
89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cisplatin; Drug Resistance, Neoplasm; Female; HSP90 Heat-Shock Proteins; Immunohistochemistry; Isoxazoles; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Resorcinols; Tissue Distribution; Vascular Endothelial Growth Factor A; Zirconium | 2010 |
Cerenkov luminescence imaging of medical isotopes.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Beta Particles; Deferoxamine; Diagnostic Imaging; Drug Evaluation, Preclinical; Electrons; Female; Humans; Luminescence; Male; Mice; Neoplasm Transplantation; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Zirconium | 2010 |
Positive progress in immunoPET--not just a coincidence.
Topics: Animals; Antibodies; Clinical Trials as Topic; Copper Radioisotopes; Drug Evaluation, Preclinical; Fluorine Radioisotopes; Humans; Immunoconjugates; Immunoglobulin Fragments; Iodine Radioisotopes; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Recombinant Fusion Proteins; Tissue Distribution; Zirconium | 2010 |
Ultrasonic array of thick film transducers for biological tissue characterization.
Topics: Electrodes; Humans; Lead; Models, Biological; Neoplasms; Phantoms, Imaging; Titanium; Transducers; Ultrasonography; Zirconium | 2010 |
An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
Topics: Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Chlorides; DNA Topoisomerases, Type II; Halogenation; Humans; Neoplasms; Podophyllotoxin; Topoisomerase II Inhibitors; Zirconium | 2011 |
MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
Topics: Animals; Binding, Competitive; Cell Line, Tumor; Humans; Integrin alphaVbeta3; Intercellular Signaling Peptides and Proteins; Iodine Radioisotopes; Ligands; Mice; Mice, Nude; Neoplasms; Oligopeptides; Peptides; Positron-Emission Tomography; Tissue Distribution; Zirconium | 2011 |
Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system.
Topics: Animals; Autoradiography; Deferoxamine; Drug Stability; Humans; Image Processing, Computer-Assisted; Iron Chelating Agents; Male; Mice; Neoplasm Transplantation; Neoplasms; Permeability; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Serum Albumin; Tissue Distribution; Transplantation, Heterologous; Ultrasonography; Zirconium | 2011 |
89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging.
Topics: Animals; Cell Line, Tumor; Dextrans; Half-Life; Humans; Isotopes; Macrophages; Mice; Nanoparticles; Neoplasms; Positron-Emission Tomography; Zirconium | 2011 |
Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging.
Topics: Copper Radioisotopes; Humans; Iodine Radioisotopes; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes; Zirconium | 2012 |
Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer.
Topics: Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Erythrocytes; Female; HEK293 Cells; Humans; Macrophages; Materials Testing; Mice; Nanoparticles; Neoplasms; Particle Size; Zirconium | 2013 |
Immuno-PET for tumor targeting.
Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Humans; Isotope Labeling; Mice; Neoplasms; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed; Zirconium | 2003 |
Application of positron-emitting zirconium-89 for potential use in brain tumor localization.
Topics: Brain Neoplasms; Electrons; Humans; Neoplasms; Radioactivity; Radioisotopes; Zirconium | 1958 |
The effect of zirconium citrate on the latent period of Sr89-induced bone cancer in mice.
Topics: Animals; Bone and Bones; Bone Neoplasms; Citrates; Citric Acid; Mice; Neoplasms; Osteosarcoma; Strontium; Strontium Radioisotopes; Zirconium | 1960 |
A comparison between the late effects of thorotrast and a non-radioactive zirconium hydroxide sol in mice.
Topics: Animals; Hydroxides; Liver Neoplasms; Mice; Neoplasms; Neoplasms, Experimental; Polymethyl Methacrylate; Thorium; Thorium Dioxide; Zirconium | 1963 |
COLLOIDAL ZIRCONYL PHOSPHATE P 32 IN THE TREATMENT OF CHRONIC LEUKEMIA AND LYMPHOMAS.
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Phosphates; Phosphorus Isotopes; Zirconium | 1964 |
ZIRCONIUM CITRATE REDUCES SR-90 BODY BURDEN.
Topics: Acetazolamide; Animals; Body Burden; Citrates; Citric Acid; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiation; Radiation-Protective Agents; Radiometry; Research; Strontium Isotopes; Zirconium | 1964 |
REDUCTION OF STRONTIUM-90 BONE CANCER BY ZIRCONIUM CITRATE.
Topics: Acetazolamide; Animals; Bone Neoplasms; Chelating Agents; Citrates; Citric Acid; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiometry; Research; Strontium; Strontium Isotopes; Zirconium | 1964 |
Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Cell Line, Tumor; Humans; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasms; Organ Specificity; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Radioisotopes; Radiopharmaceuticals; Receptors, Growth Factor; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Zirconium | 2008 |
Comparison of "direct" and "indirect" zirconyl-phosphate technics for carcinoembryonic antigen determination in plasma from patients having benign or malignant disease.
Topics: Carcinoembryonic Antigen; Humans; Neoplasms; Radioimmunoassay; Zirconium | 1980 |
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice.
Topics: Animals; Antibodies, Monoclonal; Deferoxamine; Immunoconjugates; Isotope Labeling; Mice; Mice, Nude; Neoplasms; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Tumor Cells, Cultured; Zirconium | 1997 |
Quantitative measurement and chromatography of human urinary carcinoembryonic antigen activity.
Topics: Adolescent; Adult; Carcinoembryonic Antigen; Child; Child, Preschool; Chromatography; Female; Guanidines; Humans; Hydrogen-Ion Concentration; Infant; Infant, Newborn; Male; Mercaptoethanol; Molecular Weight; Neoplasms; Radioimmunoassay; Urea; Zirconium | 1974 |
Evaluation of a new radioimmunoassay method for carcinoembryonic antigen in plasma, with use of zirconyl phosphate gel.
Topics: Adolescent; Adult; Animals; Antibody Specificity; Antigen-Antibody Complex; Antigens; Antigens, Neoplasm; Chemical Precipitation; Colon; Dialysis; Female; Gels; Glycoproteins; Goats; Humans; Immune Sera; Indicators and Reagents; Iodine Isotopes; Male; Methods; Middle Aged; Neoplasms; Protein Binding; Quality Control; Radioimmunoassay; Zirconium | 1972 |
Specificity of the carcinoembryonic antigen (CEA).
Topics: Adenocarcinoma; Adult; Antigens; Antigens, Neoplasm; Colonic Neoplasms; Embryo, Mammalian; Female; Gastrointestinal Neoplasms; Gels; Humans; Immune Sera; Methods; Neoplasms; Phosphates; Pregnancy; Radioimmunoassay; Serologic Tests; Zirconium | 1971 |
Demonstration of an antigen common to several varieties of neoplasia.
Topics: Adenocarcinoma; Aged; Animals; Antigens; Antigens, Neoplasm; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Embryo, Mammalian; Female; Gels; Goats; Humans; Immune Sera; Iodine Isotopes; Lung Neoplasms; Male; Methods; Middle Aged; Neoplasms; Phosphates; Pregnancy; Prostatic Neoplasms; Radioimmunoassay; Zirconium | 1971 |